Leveraging patient-derived cutaneous neurofibroma organoid models to identify biomarkers of drug response

syn51301409

Created By NF Service nf-osi-service

grantDOI: https://doi.org/10.54464/pc.gr.160969
studyName: Leveraging patient-derived cutaneous neurofibroma organoid models to identify biomarkers of drug response
dataStatus: Under Embargo
initiative: Biology and Therapeutic Development for Cutaneous Neurofibromas
studyLeads: Alice Soragni Sara Gosline
studyStatus: Active
diseaseFocus: Neurofibromatosis type 1
grantEndDate: 1785456000000
institutions: University of California, Los Angeles Pacific Northwest National Laboratory
fundingAgency: NTAP
embargoEndDate: 1801353600000
grantStartDate: 1682899200000
relatedStudies: syn51116567 syn11374354 syn4939892 syn4939910
studyFileviewId: syn51301431
syn51301410
syn53164954
syn51301411
syn64954273
syn64938443
syn64938444
syn64954302
syn65472970
syn64938445
syn64938446
syn64938448
syn51301431
syn51301412
syn65473029
syn65903810

Leveraging patient-derived cutaneous neurofibroma organoid models to identify biomarkers of drug response page is loading…